Angiotech Pharmaceuticals Inc – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/12 FY 2012

ended 09/30/12 Q3

ended 06/30/12 Q2 2012 – amended

ended 06/30/12 Q2 2012 – amended

ended 06/30/12 Q2

Prospectuses and Registrations Filter

Securities registration termination

Amendment to registration of securities for employees

Application for qualification of trust indentures – amended

Application for qualification of trust indentures – amended

Application for qualification of trust indentures – amended

Ownership Filter

Highland Capital Management LP

Highland Crusader Offshore Partners, L.P.

Highland Capital Management LP

Highland Crusader Offshore Partners, L.P.

News Filter

Announces Financial Results for the Fourth Quarter Ended December 31, 2012

Announces Sale of Interventional Products Business to Argon Medical Devices, Inc

NOTICE OF OPTIONAL PARTIAL REDEMPTION Senior Secured Floating Rate Notes Due 2013 of Angiotech Pharmaceuticals, Inc. CUSIP No. 034918AH5*

Change in Directors, Officers or Compensation

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Definitive proxy

Other Filter

Confidential treatment order

Notice of effectiveness

Confidential treatment order

Notice of effectiveness

Letter from the SEC